You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma

Article metrics

Article menu

Download PDFPDF

XML
Research Article
Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma

 

Online download statistics by month:

Online download statistics by month: January 2020 to January 2026

AbstractFullPdf
Jan 202011110
Feb 202071710
Mar 202045450
Apr 2020373727
May 2020383812
Jun 2020414133
Jul 2020545432
Aug 2020646435
Sep 2020838340
Oct 2020454546
Nov 2020333320
Dec 2020535325
Jan 2021737344
Feb 2021858540
Mar 202111311331
Apr 202111211229
May 202111111129
Jun 202112512549
Jul 202110010028
Aug 2021909218
Sep 2021959530
Oct 2021979832
Nov 202110610639
Dec 202111211328
Jan 202211912624
Feb 2022909027
Mar 2022444431
Apr 2022495229
May 2022485231
Jun 2022515610
Jul 202210310826
Aug 202212813216
Sep 202212913423
Oct 202220020829
Nov 202212312424
Dec 202210811319
Jan 202312712824
Feb 202310610930
Mar 202315015327
Apr 202312012435
May 20239810019
Jun 2023979913
Jul 202312212321
Aug 202310911018
Sep 2023909111
Oct 202311511521
Nov 2023838310
Dec 2023959618
Jan 2024434321
Feb 2024747427
Mar 202411311331
Apr 202410710726
May 2024929221
Jun 2024818116
Jul 202410010024
Aug 2024818258
Sep 2024333729
Oct 2024525230
Nov 2024787911
Dec 202410710721
Jan 2025949423
Feb 2025474736
Mar 2025676729
Apr 2025858537
May 2025606130
Jun 2025565626
Jan 2026110
Total566957461699